18th November 2016

Science and Technology Committee report on leaving the EU

Brexit should not compromise the future of medical research in the UK

We have been working with the Association of Medical Research Charities (AMRC) and their other member organisations to explore the risks and potential challenges facing medical research in the UK as it prepares to exit the European Union (EU).  The findings of this work were submitted to the House of Commons Science and Technology Committee inquiry into the matter.  The Committee has now published its report on leaving the EU: implications and opportunities for science and research.

The full report can be found here.

“We are encouraged by the report from the Science and Technology Committee and the recommendations for the government to reduce uncertainty by setting out a vision for science. We echo the Committee’s recommendation on the need to attract skilled researchers and students which should not be compromised as a result of Brexit negotiations. Increased research into migraine will improve the quality of life of millions of people in the UK, enabling them to live without the pain and personal suffering that migraine brings. It will reduce the financial impact on health and social care, and the economy of this highly prevalent and debilitating condition." Hannah Verghese - Advocacy, Policy and Campaigns Manager at The Migraine Trust
“We welcome the Committee’s report published this morning and its recommendations that chime with not only our position, but with those across the sector. It is particularly encouraging that the Committee picked up from the evidence we submitted that patients must not face delays in accessing novel treatments. Uncertainty about the future of the UK’s world class science base is not only a major concern for medical research in terms of attracting those essential to the research field and inward investment but also to those who benefit from it the most – patients..." Aisling Burnand - Chief Executive of the AMRC

Read the full statement from the AMRC here.

Read more about migraine research at the heart of our work here.


Other news